Immunological characterization of a VIR protein family member (VIR-14) in Plasmodium vivax-infected subjects from different epidemiological regions in Africa and South America
PLOS Neglected Tropical Diseases · 2023
DOI: 10.1371/journal.pntd.0011229 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2023. Verfasst von Raianna F Fantin und 15 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesd…. Hauptthemen laut MEDLINE: Malaria, Vivax, Malaria, Falciparum. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: Intramural NIH HHS, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Plasmodium vivax is a major challenge for malaria control due to its wide geographic distribution, high frequency of submicroscopic infections, and ability to induce relapses due to the latent forms present in the liver (hypnozoites). Deepening our knowledge of parasite biology and its molecular components is key to develop new tools for malaria control and elimination. This study aims to investigate and characterize a P . vivax protein ( Pv Vir14) for its role in parasite biology and its interactions with the immune system. We collected sera or plasma from P . vivax -infected subjects in Brazil (n = 121) and Cambodia (n = 55), and from P . falciparum- infected subjects in Mali (n = 28), to assess antibody recognition of Pv Vir14. Circulating antibodies against Pv Vir14 appeared in 61% and 34.5% of subjects from Brazil and Cambodia, respectively, versus none (0%) of the P . falciparum -infected subjects from Mali who have no exposure to P . vivax . IgG1 and IgG3 most frequently contributed to anti- Pv Vir14 responses. Pv Vir14 antibody levels correlated with those against other well-characterized sporozoite/liver ( Pv CSP) and blood stage ( Pv DBP-RII) antigens, which were recognized by 7.6% and 42% of Brazilians, respectively. Concerning the cellular immune profiling of Brazilian subjects, Pv Vir14 seroreactive individuals displayed significantly higher levels of circulating atypical (CD21 − CD27 − ) B cells, raising the possibility that atypical B cells may be contribute to the Pv Vir14 antibody response. When analyzed at a single-cell level, the B cell receptor gene hIGHV3-23 was only seen in subjects with active P . vivax infection where it comprised 20% of V gene usage. Among T cells, CD4 + and CD8 + levels differed (lower and higher, respectively) between subjects with versus without antibodies to Pv Vir14, while NKT cell levels were higher in those without antibodies. Specific B cell subsets, anti- Pv Vir14 circulating antibodies, and NKT cell levels declined after treatment of P . vivax . This study provides the immunological characterization of Pv Vir14, a unique P . vivax protein, and possible association with acute host’s immune responses, providing new information of specific host-parasite interaction. Trial registration : TrialClinicalTrials.gov Identifier: NCT00663546 & ClinicalTrials.gov NCT02334462 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Maryland, United States of America.
- School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil.
- Department of Parasitology, Federal University of Minas Gerais, Belo Horizonte, Brazil.
- Center for Research in Tropical Medicine, Porto Velho, Brazil.
- National Center for Parasitology, Entomology, and Malaria Control, Phnom Penh, Cambodia.
- Faculty of Medicine and Odonto-Stomatology, University of Sciences, Techniques and Technology of Bamako, Bamako, Mali.
ORCID-Profile: Lilian L Bueno
Förderung
- Intramural NIH HHS
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Fantin, R. F., Coelho, C. H., Berhe, A. D., Magalhães, L. M. D., Pereira, D. B., Salinas, N. D., Tolia, N. H., Amaratunga, C., Suon, S., Sagara, I., Narum, D. L., Fujiwara, R. T., Abejon, C., Campos-Neto, A., Duffy, P. E., & Bueno, L. L. (2023). Immunological characterization of a VIR protein family member (VIR-14) in Plasmodium vivax-infected subjects from different epidemiological regions in Africa and South America. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0011229
Vancouver
Fantin RF, Coelho CH, Berhe AD, Magalhães LMD, Pereira DB, Salinas ND, et al. Immunological characterization of a VIR protein family member (VIR-14) in Plasmodium vivax-infected subjects from different epidemiological regions in Africa and South America. PLOS Neglected Tropical Diseases. 2023. doi:10.1371/journal.pntd.0011229
BibTeX
@article{Fantin2023,
author = {Fantin, Raianna F and Coelho, Camila H and Berhe, Anne D and Magalhães, Luisa M D and Pereira, Dhélio B and Salinas, Nichole D and Tolia, Niraj H and Amaratunga, Chanaki and Suon, Seila and Sagara, Issaka and Narum, David L and Fujiwara, Ricardo T and Abejon, Claudia and Campos-Neto, Antonio and Duffy, Patrick E and Bueno, Lilian L},
title = {Immunological characterization of a VIR protein family member (VIR-14) in Plasmodium vivax-infected subjects from different epidemiological regions in Africa and South America},
journal = {PLOS Neglected Tropical Diseases},
year = {2023},
doi = {10.1371/journal.pntd.0011229}
}
EUVIMED